Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR




  • Top policymakers and business leaders from Africa and the Republic of Korea gathered in Paris on Tuesday to discuss regional integration, industrial productivity and ways to further economic growth and cooperation.
  • Over 150 leaders attended the Africa-Korea Business Summit. Speakers at the event included Wamkele Mene, Secretary-General of the African Continental Free Trade Area (AfCFTA), Albert Muchanga, African Union (AU) Commissioner for Trade and Industry, Jang Sung-min, Special Envoy and Senior Secretary to the President for Future Strategy of the ROK, Mzé Abdou Mohamed Chanfiou, Finance Minister of the Union of Comoros, Sim Thsabalala, CEO of Standard Bank and Yu Jeong-joon, Vice Chairman of SK Group

SEOUL, South Korea, Sept. 14, 2023 /PRNewswire/ — The Africa-Korea Business Summit was hosted at the Peninsula Hotel in Paris by the Korea-Africa Foundation and the Korea Chamber of Commerce and Industry (KCCI) with support from the Ministry of Foreign Affairs of the Republic of Korea. The theme for the business summit was Africa-Korean partnership in an era of great transformation.’

The President of the Korea- Africa Foundation, Lyeo Woon-ki stated ‘This summit was organized to lay the foundation for ‘2024 Korea-Africa Summit’ scheduled for next year and to provide an opportunity for Korean companies to explore market entry strategies into Africa and enhance their understanding of cooperation measures, especially given the full implementation phase of the AfCFTA that commenced in 2021.” The Korean government plans to host the Korea-Africa Summit in 2024 in Korea.

The AfCFTA is the most extensive free trade zone both in terms of geographical coverage and the number of participating countries since the inception of the World Trade Organization (WTO). Fifty-four of the 55 African Union countries (excluding Eritrea) are members of the organization, representing 1.3 billion people and the economic bloc boasts a collective GDP of $3.4 trillion.

The summit featured presentations and in-depth discussions on topics including economic integration, trade, industrialization and productivity gaps, and opportunities for collaboration with Korean businesses and investors across a range of industries including agriculture, mining, energy, renewables, manufacturing and digitalization.

The sessions were attended by over 150 participants, including Wamkele Mene, Secretary-General of the AfCFTA; Albert Muchanga, Commissioner for Trade and Industry of the African Union Commission; Jang Sung-min, Special Envoy and Senior Secretary to the President for Future Strategy of the ROK; Sim Tshabalala, joint Chief Executive of the Standard Bank Group; Ban Ki-moon, former UN Secretary-General; Yu Jeong-joon, Vice Chairman and Head of U.S. Government & Corporate Affairs for SK Group; and Seo Sang-hyun, Senior Researcher at POSCO.

Former UN Secretary-General Ban Ki-moon, in a video message delivered to commemorate the event, said, ‘The Africa-Korea Business Summit is an excellent initiative’, adding that ‘Africa stands at a critical juncture and the continent is entering a new phase of high-powered economic integration.’


Mr. Ban elaborated by saying, “Africa is rapidly emerging as the world’s largest growth market,” and he went on to emphasize, “Without Africa, we cannot supply the impetus for green revolution or address pressing global issues such as the climate crisis.”

Wamkele Mene, Secretary-General of the AfCFTA, delivered remarks during the session on the day, stating ”Challenges in Africa also act as opportunity for investors. ‘Hyundai’ could build manufacturing bases in Africa and ‘Samsung’ could expand theirs, not just in South Africa and Egypt as they do now.”  

Choi Kyong-lim, former Korean representative for WTO CTG stated “Geographically Korea is a very small country, however, our trade volume is the ultimate opposite with being ranked one of the biggest economy in the world. But the trade volume between Africa and Korea is less than 2 percent.” and encouraged the participants “to put efforts for enhancing the economic partnership between Africa and Korea.”

Also, Mr. Choi mentioned 2024 Korea-Africa Summit and urged Africa to support 2030 Busan EXPO which would be a significant business opportunity to Africa.

Jang Sung-min, Special Envoy and Senior Secretary to the President for Future Strategy of the ROK who represented President Yoon Suk-yeol at the event said that ”Africa is being elevated as the biggest and the most important growth hub in the global arena. Major efforts for the regional integration with AfCFTA will be the gateway to Africa’s boundless potential. Prosperous Africa accords with not only international community but also with Korea, creating opportunities of new market to Korean private sectors upon the mutually beneficial genuine partnership”


Albert Muchanga, AU Commissioner for Trade and Industry who participated in a panel on industry and the great productivity gap in Africa stated that “Increasing productivity growth is imperative to achieving inclusive growth and sustainable development across Africa.” and “As Korea’s development experience, overcoming the productivity gap by investing in human capital development and utilization is a lesson to Africa and with the partnership between Korea and Africa, the continent will become a key engine of global economic expansion.”

Vice President Yu for International Cooperation at SK Group, the second-largest conglomerate in Korea, said, ‘I am honored to participate in this business summit, which will explore new opportunities for cooperation between the Korean private sector and African countries.’ He further stated, ‘Given the continent’s unlimited business potential, it is crucial to strengthen bilateral relations and enhance our understanding of African nations.’

‘This summit holds even greater significance as it elevates itself beyond a business forum’, said Lyeo Woon-Ki, President of Korea-Africa Foundation, and he expressed his hope that it would serve as a meaningful opportunity for shaping new cooperation initiatives between Korea and Africa.

Photo – 

Cision View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting


The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision


The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895


EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”


Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.


BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading